Guest guest Posted August 1, 2008 Report Share Posted August 1, 2008 Shares of Biogen Idec Inc. and Elan Corp. fell sharply in late trading Thursday, after the companies said their multiple sclerosis drug Tysabri has been linked to two new cases of a rare and often fatal brain inflammation. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.